KT-Acryl to Pursue Medical AX Projects... Standardize Data and Validate AI Services

Develop AX business models tailored to medical institutions
Explore government and public research projects and new business opportunities

KT said on October 20 that it had signed a memorandum of understanding (MOU) with Acryl, a company specializing in medical artificial intelligence (AI), to pursue medical AI transformation (AX) projects.

Noh Hyungrae, head of the Corporate Business Division in KT's Enterprise Business Division (right), and Park Oejin, CEO of Acryl, pose for a commemorative photo after signing an agreement to pursue a medical AX business. Photo provided by KT.

The partnership aims to jointly develop AX business models tailored to medical institutions. It will combine KT's capabilities in integrated implementation based on AI, cloud and data, and its experience in medical AX projects, with Acryl's expertise in medical data and AI technology, as well as its experience implementing and validating solutions at hospitals.

In response to growing demand for data use and AI services in healthcare, the two companies will work together to establish a foundation for standardizing and using medical data; jointly identify and validate medical AI technologies and services; and pursue medical AI research and development, commercialization and expansion. They plan to jointly propose and validate projects with medical institutions and establish a framework for cooperation that spans technology verification through actual commercialization. They will also explore government and public research projects, as well as opportunities for new business.

KT has unveiled a “medical standardization model” that covers everything from infrastructure tailored to each hospital's needs to data platforms and AI services. The company is using the model to support the adoption of AX at tertiary general hospitals and general hospitals across the country, and plans to expand its applications in cooperation with specialized medical partners.

“Acryl has built up the technology framework and on-the-ground experience to connect every stage, from linking and using medical data to developing and operating specialized AI models,” said Park Oejin, CEO of Acryl. “Through our partnership with KT, we will expand business opportunities in Korea's medical AI market and broaden the areas where AI can be applied across various industries.”

“The key to medical AX is connecting the data hospitals hold so it can be used in actual care, research and operations, bringing changes that people can feel on the ground,” said Roh Hyungrae, head of the Corporate Business Headquarters in KT's Enterprise Division and a managing director. “By working with Acryl, we will strengthen the foundation for deploying medical AX services in the field and pursue hospital-specific projects linked to KT's medical standardization model, helping drive the wider adoption of medical AX.”

This content was produced with the assistance of AI translation services.